ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,967.23
      -0.88%
      US Tech 100
      16,556.80
      -2.24%
      Dow Jones
      37,986.40
      0.56%
      Brent Oil
      86.625
      0.00%
      Bitcoin
      63,692.27
      -0.21%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Five Prime Therapeutics Inc (FPRX)

      7. Five Prime Therapeutics Inc (FPRX) News

      FPRX

      Five Prime Therapeutics (FPRX)

      Five Prime Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FPRX
      DateTimeSourceHeadlineSymbolCompany
      02/15/20226:39AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FPRXFive Prime Therapeutics Inc
      05/17/20214:44PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/22/20216:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/20/202111:28AMTipRanksAmgen Completes The Acquisition Of Five Prime TherapeuticsNASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/19/20217:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20214:16PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20214:16PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20214:15PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20214:08PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20214:08PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20214:07PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20214:07PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20214:02PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20218:48AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20218:43AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20218:39AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20218:38AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/16/20218:25AMPR Newswire (US)Amgen Successfully Completes Acquisition Of Five Prime TherapeuticsNASDAQ:FPRXFive Prime Therapeutics Inc
      04/15/20214:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/08/20216:09AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FPRXFive Prime Therapeutics Inc
      04/06/20218:02AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FPRXFive Prime Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:FPRX